Showing 2642 results
- Media Release /Gilbert Ghostine, CEO of the Swiss multi-national fragrances business Firmenich appointed Chairman-Designate of the future Sandoz BoardMr Ghostine to begin role as Sandoz Chairman following the spin-…
- Media Release /Submission supported by comprehensive analytical and clinical data package Denosumab indicated for treating variety of conditions including osteoporosis in postmenopausal women1,2 Sandoz…
- Media Release /In two of the largest Phase III trials conducted in hidradenitis suppurativa (HS), Cosentyx® (secukinumab) treatment response rates continued to improve beyond the primary endpoint analysis at Week…
- Key Release /Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +4% (cc1, -2% USD) with core operating income growing +8% (cc, 0% USD) IM sales grew +4% (cc, -2% USD) and core operating income…
- In The News /How changes driven by COVID-19 may shape pharma manufacturing in the long term.
- In The News /What are the key factors ensuring Novartis supply chains remain operational during the pandemic?
- In The News /Novartis Technical Operations adapts to meet drug donation plans and ensure business continuity.
- In The News /Steffen Lang, Global Head Novartis Technical Operations, on communication, data and automation during the COVID-19 crisis.
- In The News /Balancing priorities of combating the crisis and ongoing trials.
Pagination
- ‹ Previous page
- 1
- …
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- …
- 265
- › Next page